We are excited to introduce our new Director Dr. Béranger Lueza who joined our international Modelling, Access and Strategy unit this week. Béranger is based in Stockholm and has more […]
Earlier this week the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) based primarily on real-world evidence (RWE). The decision reflects the increasing importance of real-world data (RWD) […]
Today we are delighted to introduce Ethan O’Leary who joined our Stockholm team as a Research Analyst this Monday!
Ethan is currently finishing his Master’s in Economics from Stockholm School […]
Quantify’s Christoph Abé (PhD) publishes the largest-ever study associating bipolar disorder with abnormal brain changes over time in the renowned journal Biological Psychiatry, using neuroimaging data.
—
Our Lead Analyst, Christoph Abé (PhD) led an international […]
Check out this recent publication from Quantify, presenting a new conceptual framework in psoriasis that differentiates psoriasis severity from disease control (Link to article: https://onlinelibrary.wiley.com/doi/10.1111/bjd.21023https://lnkd.in/gJtZtENB). Authored by Quantify’s CEO Kirk Geale, […]
At Quantify, we work a lot with ICD codes. And we mean a lot! So much, in fact, that we have discovered some pretty obscure codes that you might not be aware […]
The 28th February is #rarediseaseday and we at Quantify want to help spread awareness of this important day as an estimated 300 million people of the world’s population are currently living with a rare disease.
At Quantify we are determined to […]
Quantify is delighted to welcome Naveen Sharma, who is joining our India office as Manager in the Evidence Generation team. Naveen is carrying more than seven years of consulting experience in Health Economics & Outcome Research. He has in-depth knowledge […]